Massoumi R - Search Results

1

CYLD: a deubiquitination enzyme with multiple roles in cancer.

Massoumi R. Massoumi R. Future Oncol. 2011 Feb;7(2):285-97. doi: 10.2217/fon.10.187. Future Oncol. 2011. PMID: 21345146 Review.

2

Tetraploidization Increases the Motility and Invasiveness of Cancer Cells.

Jemaà M, Daams R, Charfi S, Mertens F, Huber SM, Massoumi R. Jemaà M, et al. Among authors: massoumi r. Int J Mol Sci. 2023 Sep 10;24(18):13926. doi: 10.3390/ijms241813926. Int J Mol Sci. 2023. PMID: 37762227 Free PMC article.

3

Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.

Massoumi R, Paus R. Massoumi R, et al. Bioessays. 2007 Dec;29(12):1203-14. doi: 10.1002/bies.20677. Bioessays. 2007. PMID: 18008375 Review.

4

Ubiquitin chain cleavage: CYLD at work.

Massoumi R. Massoumi R. Trends Biochem Sci. 2010 Jul;35(7):392-9. doi: 10.1016/j.tibs.2010.02.007. Epub 2010 Mar 26. Trends Biochem Sci. 2010. PMID: 20347313 Review.

5

Serum response factor controls CYLD expression via MAPK signaling pathway.

Liang G, Ahlqvist K, Pannem R, Posern G, Massoumi R. Liang G, et al. Among authors: massoumi r. PLoS One. 2011 May 5;6(5):e19613. doi: 10.1371/journal.pone.0019613. PLoS One. 2011. PMID: 21573132 Free PMC article.

6

GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma.

Kuphal S, Shaw-Hallgren G, Eberl M, Karrer S, Aberger F, Bosserhoff AK, Massoumi R. Kuphal S, et al. Among authors: massoumi r. Oncogene. 2011 Nov 3;30(44):4523-30. doi: 10.1038/onc.2011.163. Epub 2011 May 16. Oncogene. 2011. PMID: 21577203

7

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

Masoumi KC, Shaw-Hallgren G, Massoumi R. Masoumi KC, et al. Among authors: massoumi r. J Skin Cancer. 2011;2011:614097. doi: 10.1155/2011/614097. Epub 2011 Dec 17. J Skin Cancer. 2011. PMID: 22235375 Free PMC article.

8

CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.

Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R. Pannem RR, et al. Among authors: massoumi r. Carcinogenesis. 2014 Feb;35(2):461-8. doi: 10.1093/carcin/bgt335. Epub 2013 Oct 8. Carcinogenesis. 2014. PMID: 24104553

9

Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

Kobayashi T, Masoumi KC, Massoumi R. Kobayashi T, et al. Among authors: massoumi r. Oncogene. 2015 Apr 23;34(17):2251-60. doi: 10.1038/onc.2014.159. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909169

10

Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells.

Zarrizi R, Menard JA, Belting M, Massoumi R. Zarrizi R, et al. Among authors: massoumi r. Cancer Res. 2014 Nov 15;74(22):6499-508. doi: 10.1158/0008-5472.CAN-14-0221. Epub 2014 Sep 16. Cancer Res. 2014. PMID: 25228651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page